|
Asuragen, Inc. has announced the immediate availability of its miRInform® Pancreas Test in its CAP-accredited CLIA Laboratory. The test was developed to aid physicians in the diagnosis and management of pancreatic ductal adenocarcinoma (PDAC) when cytology is inconclusive.
Tags: pancreatic cancer, miRNA
|
|
Show per page
1 of 225 Page
1 2 3 ... Next
|
|
|
Popular tags in SelectScience